Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

Share Price is delayed by 15 minutes
Get Live Data
55.50    -0.50 (-0.89%)
Bid:
55.00
Ask:
56.00
Spread: 1.00 (1.818%)
Market Cap: £8.45m
TRT Live PriceLast checked at - London Stock Exchange

Intraday Transense Share Chart

Further Update

21 Nov 2007 07:30

Transense Technologies PLC21 November 2007 Transense Technologies plc ("Transense" or the "Company") Further update Further to the Company's announcement on 16 November 2007, the Company has nowcompleted its assessment of its position and is pleased to announce that it hastoday entered into a subscription agreement with Peter Lobbenberg, an existingshareholder in the Company, for the subscription (either by himself or throughconnected persons) of 1,043,500 Ordinary Shares in the Company at 23 pence pershare, raising a total of £240,005 for the Company. The proposed subscriptiondoes not require shareholder approval, is unconditional and is expected tocomplete within the next 10 business days. Peter Lobbenberg has notified theCompany that (excluding the Ordinary Shares to be acquired pursuant to thissubscription) he is currently interested in 2,625,936 Ordinary Shares in theCompany, representing 4.62% of its issued share capital. The Directors believethat this subscription will mean that, in the absence of unforeseencircumstances, the Company will have sufficient working capital until the end ofFebruary 2008. The Company is now seeking to undertake an additional fundraising before theyear end. To this end, discussions with certain shareholders of the Company(including Peter Lobbenberg), who have indicated they would support afundraising for in excess of £3 million of Ordinary Shares at a minimum of 23pence per Ordinary Share, are progressing well. The Company is working tofinalise this expeditiously although final legal documentation has yet to beagreed and the details have not yet been discussed with the Company's financialadvisers. Shareholder approval by way of a special resolution will be requiredfor such fundraising. Failure to effect such an additional fundraising beforethe end of February 2008 could result in the Company having to cease operations. The Company is now focusing on securing this fundraising and on its currenttrading activities. A further update on the fundraising will be announced indue course and the Company expects that trading in its shares will recommenceimmediately. Enquiries: Transense Technologies plc 01869 238 380Jim Perry / Peter Woods Noble & Company Limited 020 7763 2200John Llewellyn-Lloyd / Graeme Bayley This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
20th Nov 20243:22 pmRNSHolding(s) in Company
30th Oct 20245:27 pmRNSDirector/PDMR Shareholding - acquisition of shares
21st Oct 20247:00 amRNSPosting of Annual Report & Notice of AGM
10th Oct 202411:05 amRNSDirector/PDMR Shareholding - acquisition of shares
27th Sep 202411:28 amRNSHolding(s) in Company
26th Sep 202410:42 amRNSHolding(s) in Company
23rd Sep 20247:00 amRNSFinal Results & Investor Presentation
18th Sep 20247:00 amRNSTransense Selected for £11 Million EV R&D Project
3rd Sep 20247:00 amRNSNotice of Annual Results & Investor Presentation
1st Aug 202410:35 amRNSDirector/PDMR shareholding – acquisition of shares
17th Jul 20247:00 amRNSGrant of Share Options
16th Jul 20247:00 amRNSTrading Update
26th Jun 20247:00 amRNSAppointment of Independent Non-Executive Director
18th Jun 20247:00 amRNSDirector/PDMR Shareholding – acquisition of shares
30th May 20245:25 pmRNSHolding(s) in Company
30th May 20245:20 pmRNSHolding(s) in Company
24th May 20247:00 amRNSHolding(s) in Company
13th May 20247:00 amRNSUpcoming Investor & Analyst Events
10th May 20244:50 pmRNSHolding(s) in Company
1st May 20247:00 amRNSDirector/PDMR - Acquisition of Shares
30th Apr 20245:00 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSTRT joins £37.8m LANDOne project with Airbus & ATI
17th Apr 20246:00 pmRNSTransaction in Own Shares & TVR
15th Apr 20242:51 pmRNSTransaction in Own Shares & TVR
28th Mar 20245:00 pmRNSTotal Voting Rights
25th Mar 20243:35 pmRNSTransaction in Own Shares & TVR
20th Mar 20249:10 amRNSRyan Maughan appointed as Managing Director
29th Feb 20245:00 pmRNSTotal Voting Rights
21st Feb 20242:40 pmRNSHolding(s) in Company
19th Feb 20247:00 amRNSInterim Results & Investor Presentation
15th Feb 20247:00 amRNSHolding(s) in Company
2nd Feb 20245:41 pmRNSTransaction in Own Shares & TVR
31st Jan 20245:00 pmRNSTotal Voting Rights
12th Jan 20247:00 amRNSDirector/PDMR Shareholding
11th Jan 20249:52 amRNSTransaction in Own Shares & TVR
8th Jan 20247:00 amRNSTranslogik Update – Appointment of Sales Director
1st Dec 20237:00 amRNSGrant of share options to Director and employee
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 202311:11 amRNSDirector/PDMR Shareholding
29th Nov 20233:01 pmRNSDirector/PDMR Shareholding
29th Nov 202310:45 amRNSResult of AGM
29th Nov 20237:00 amRNSAGM Statement & Trading Update
24th Nov 20231:11 pmRNSHolding(s) in Company
9th Nov 202312:12 pmRNSDirector/PDMR Shareholding
6th Nov 20234:48 pmRNSTransaction in Own Shares & TVR
25th Oct 202310:00 amRNSPosting of Annual Report & Notice of AGM
16th Oct 20233:23 pmRNSHolding(s) in Company
3rd Oct 20236:00 pmRNSHolding(s) in Company
28th Sep 20235:22 pmRNSHolding(s) in Company
27th Sep 20233:18 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.